Patents by Inventor Fred Drake

Fred Drake has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human osteoclast derived cathepsin
    Publication number: 20060024299
    Abstract: Disclosed is a human osteoclast-derived cathepsin (Cathepsin O) polypeptide and DNA(RNA) encoding such cathepsin O polypeptides. Also provided is a procedure for producing such polypeptide by recombinant techniques. The present invention also discloses antibodies, antagonists and inhibitors of such polypeptide which may be used to prevent the action of such polypeptide and therefore may be used therapeutically to treat bone diseases such as osteoporosis and cancers, such as tumor metastases.
    Type: Application
    Filed: July 21, 2005
    Publication date: February 2, 2006
    Applicants: Human Genome Sciences, Inc., SmithKline Beecham Corp.
    Inventors: Gregg Hastings, Mark Adams, Claire Fraser, Norman Lee, Ewen Kirkness, Judith Blake, Lisa Fitzgerald, Fred Drake, Maxine Gowan
  • Human osteoclast derived cathepsin
    Publication number: 20050019889
    Abstract: Disclosed is a human osteoclast-derived cathepsin (Cathepsin O) polypeptide and DNA(RNA) encoding such cathepsin O polypeptides. Also provided is a procedure for producing such polypeptide by recombinant techniques. The present invention also discloses antibodies, antagonists and inhibitors of such polypeptide which may be used to prevent the action of such polypeptide and therefore may be used therapeutically to treat bone diseases such as osteoporosis and cancers, such as tumor metastases.
    Type: Application
    Filed: December 4, 2003
    Publication date: January 27, 2005
    Applicants: Human Genome Sciences, Inc., SmithKline Beecham Corporation
    Inventors: Gregg Hastings, Mark Adams, Claire Fraser, Norman Lee, Ewen Kirkness, Judith Blake, Lisa Fitzgerald, Fred Drake, Maxine Gowan